159 related articles for article (PubMed ID: 10973820)
1. CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity.
Shin SY; Kang SW; Lee DG; Eom SH; Song WK; Kim JI
Biochem Biophys Res Commun; 2000 Sep; 275(3):904-9. PubMed ID: 10973820
[TBL] [Abstract][Full Text] [Related]
2. CRAMP analog having potent antibiotic activity without hemolytic activity.
Kang SW; Lee DG; Yang ST; Kim Y; Kim JI; Hahm KS; Shin SY
Protein Pept Lett; 2002 Aug; 9(4):275-82. PubMed ID: 12144503
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy.
Yu K; Park K; Kang SW; Shin SY; Hahm KS; Kim Y
J Pept Res; 2002 Jul; 60(1):1-9. PubMed ID: 12081622
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic activity of Leu-Lys rich model peptides.
Park Y; Lee DG; Hahm KS
Biotechnol Lett; 2003 Aug; 25(16):1305-10. PubMed ID: 14514057
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.
Shin SY; Lee SH; Yang ST; Park EJ; Lee DG; Lee MK; Eom SH; Song WK; Kim Y; Hahm KS; Kim JI
J Pept Res; 2001 Dec; 58(6):504-14. PubMed ID: 12005420
[TBL] [Abstract][Full Text] [Related]
6. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Kang JH; Hahm KS
J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
[TBL] [Abstract][Full Text] [Related]
7. Novel designed VmCT1 analogs with increased antimicrobial activity.
Pedron CN; Torres MT; Lima JADS; Silva PI; Silva FD; Oliveira VX
Eur J Med Chem; 2017 Jan; 126():456-463. PubMed ID: 27912176
[TBL] [Abstract][Full Text] [Related]
8. Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid.
Lee DG; Kim PI; Park Y; Woo ER; Choi JS; Choi CH; Hahm KS
Biochem Biophys Res Commun; 2002 Apr; 293(1):231-8. PubMed ID: 12054589
[TBL] [Abstract][Full Text] [Related]
9. Design of novel analogue peptides with potent fungicidal but low hemolytic activity based on the cecropin A-melittin hybrid structure.
Lee DG; Park JH; Shin SY; Lee SG; Lee MK; Kim KL; Hahm KS
Biochem Mol Biol Int; 1997 Oct; 43(3):489-98. PubMed ID: 9352066
[TBL] [Abstract][Full Text] [Related]
10. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1.
Lee DG; Kim HN; Park Y; Kim HK; Choi BH; Choi CH; Hahm KS
Biochim Biophys Acta; 2002 Jul; 1598(1-2):185-94. PubMed ID: 12147359
[TBL] [Abstract][Full Text] [Related]
11. Influence of N-terminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide hylin-a1.
Crusca E; Rezende AA; Marchetto R; Mendes-Giannini MJ; Fontes W; Castro MS; Cilli EM
Biopolymers; 2011; 96(1):41-8. PubMed ID: 20560142
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity and stability of protonectin with D-amino acid substitutions.
Qiu S; Zhu R; Zhao Y; An X; Jia F; Peng J; Ma Z; Zhu Y; Wang J; Su J; Wang Q; Wang H; Li Y; Wang K; Yan W; Wang R
J Pept Sci; 2017 May; 23(5):392-402. PubMed ID: 28299840
[TBL] [Abstract][Full Text] [Related]
13. Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.
Won HS; Jung SJ; Kim HE; Seo MD; Lee BJ
J Biol Chem; 2004 Apr; 279(15):14784-91. PubMed ID: 14739294
[TBL] [Abstract][Full Text] [Related]
14. Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).
Park Y; Kim HN; Park SN; Jang SH; Choi CH; Lim HT; Hahm KS
Biotechnol Lett; 2004 Mar; 26(6):493-8. PubMed ID: 15127790
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship, conformational and biological studies of temporin L analogues.
Mangoni ML; Carotenuto A; Auriemma L; Saviello MR; Campiglia P; Gomez-Monterrey I; Malfi S; Marcellini L; Barra D; Novellino E; Grieco P
J Med Chem; 2011 Mar; 54(5):1298-307. PubMed ID: 21319749
[TBL] [Abstract][Full Text] [Related]
16. Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.
Olson L; Soto AM; Knoop FC; Conlon JM
Biochem Biophys Res Commun; 2001 Nov; 288(4):1001-5. PubMed ID: 11689009
[TBL] [Abstract][Full Text] [Related]
17. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
Conlon JM; Galadari S; Raza H; Condamine E
Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
[TBL] [Abstract][Full Text] [Related]
18. Membranolytic selectivity of cystine-stabilized cyclic protegrins.
Tam JP; Wu C; Yang JL
Eur J Biochem; 2000 Jun; 267(11):3289-300. PubMed ID: 10824115
[TBL] [Abstract][Full Text] [Related]
19. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.
Corzo G; Escoubas P; Villegas E; Barnham KJ; He W; Norton RS; Nakajima T
Biochem J; 2001 Oct; 359(Pt 1):35-45. PubMed ID: 11563967
[TBL] [Abstract][Full Text] [Related]
20. Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells.
Sal-Man N; Oren Z; Shai Y
Biochemistry; 2002 Oct; 41(39):11921-30. PubMed ID: 12269837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
